| RNCOS has recently added a new Market Research | | | | consultants and investors who are planning to enter |
| Report titled, “Booming Clinical Trials Market in | | | | the Indian clinical trials market. |
| India” to its report gallery. According to the new | | | | Our report provides forecasts on |
| RNCOS report, India promises to be one of the | | | | - Size of global clinical research outsourcing market - |
| hottest destinations for conducting global clinical | | | | Size of Indian clinical research outsourcing market - |
| research, owing to a huge patient pool representing | | | | Number of clinical trials in India - Number of patients |
| both chronic and infectious diseases, easy | | | | expected to participate in clinical trials in India - Clinical |
| recruitment of patients, and high cost savings. | | | | trials infrastructure and professionals in India - |
| India presently occupies a very small pie of the global | | | | Healthcare indicators in India |
| opportunity. The total number of clinical trials in India | | | | Key questions answered in the report |
| stood at 221 in 2007, which equates to less than 2% | | | | - Why are drug manufacturers outsourcing clinical |
| of the global clinical trials. With all major | | | | trials? - Where and how many clinical trials are being |
| pharmaceutical/biotech companies and CROs | | | | outsourced? - Where dose India stand in the global |
| establishing their presence in India, the number of | | | | clinical trials market? - How big is the clinical trials |
| clinical trials in the country is expected to grow | | | | opportunity in India? - How much does it cost on |
| several folds in the next five years. The country is | | | | hiring personnel for various clinical research processes, |
| projected to conduct nearly 5% of the global clinical | | | | rent and utilities in India as compared to other |
| trials by 2012. However, to achieve its goal of | | | | countries? - How does clinical trials infrastructure and |
| becoming a global hub of clinical trials, the country has | | | | staff in India vary from other countries? - What are |
| to overcome challenges like unethical trials, delay in | | | | various government regulations/guidelines for |
| trial approval, inappropriate protection of clinical data, | | | | conducting clinical trials in India? - What are the Future |
| and lack of Good Clinical Practice (GCP) certified sites | | | | trends predicted to shape the clinical trials market in |
| and investigators. Surging clinical trials market in India | | | | India? - How is the clinical trials market impacting |
| will create enormous opportunities for a number of | | | | associated industries? |
| associated industries, including IVD market, education | | | | Key players analyzed in the report |
| sector and clinical data management. | | | | This section provides business overview on |
| “Booming Clinical Trials Market in India” gives | | | | prominent players in the Indian clinical research |
| an extensive and objective analysis on the Indian | | | | market like Syngene International Ltd, Quintiles |
| clinical trials market. It investigates the advantages | | | | Research (India) Private Limited, Lambda Therapeutic |
| disadvantages India has in becoming a global clinical | | | | Research Ltd, Vimta Labs Limited and Veeda Clinical |
| trials hub. The report exhaustively evaluates and | | | | Research - India. |
| compares the key factors that drug companies and | | | | About RNCOS: |
| CROs look before outsourcing clinical trials to a | | | | RNCOS, incorporated in the year 2002, is an industry |
| country. These include parameters such as patient | | | | research firm. We are a team of industry experts |
| pool, regulatory environment, cost, infrastructure, | | | | who analyze data collected from credible sources. |
| human resources and past performance in conducting | | | | We provide industry insights and analysis that helps |
| clinical trials. Thus, this analytical study serves as a | | | | corporations to take timely and accurate business |
| useful guide for drug manufacturers, CROs, | | | | decision in today's globally competitive environment. |